Value Forum
Stock Alerts by Email X
Market News Video    Daily Dividends  Economic News  Large Caps  Market Movers  Upgrades/Downgrades  Weekly Market Wrap  Week Ahead Report
MNV
MNV MNV Follow marketnewsvideo on Twitter
  Stock AlertsFree email alerts when your stocks are mentioned in videos
MNV


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
MNV Backgroundemail friendsEmail Friendsembed / linkEmbed VideorssRSS FeedalertsEmail Alerts standaloneLaunch Standalone Player
Sponsored by: Try ValueForum, the premier value and income stock picking community. Learn about the $5.99 trial
QuoteI can honestly say that the information shared on ValueForum has
led me to retire earlier than expected. more testimonials »

FDA Approves United Therapeutics Drug for Hypertension
Tuesday, May 26, 11:45 AM ET

United Therapeutics announced that its drug tadalafil - better known as the erectile dysfunction treatment Cialis - has been given the go-ahead by the Food and Drug Administration for use in treating pulmonary arterial hypertension. The drug will be sold as a hypertension treatment as "Adcirca."

United Therapeutics bought the licensing rights to sell the erectile dysfunction drug for the new indication from Eli Lilly & Co. in 2008. Pfizer's Viagra is also used to treat hypertension, under the name Revatio. United Therapeutics expects to launch the drug in the U.S. in August.

United Therapeutics shares up more than 10 percent in morning trading.

For Market News Video, I'm Angela Salvucci.

FDA Approves United Therapeutics Drug for Hypertension picture
Downgrades: LLY, NVDA Downgrades: LLY, NVDA
Friday, August 13, 3:04 PM ET		 Lilly Loses Strattera Patent Ruling; Trubion to be Acquired by Emergent Biosciences Lilly Loses Strattera Patent Ruling; Trubion to be Acquired by Emergent Biosciences
Friday, August 13, 12:15 PM ET
MNV
MNV
MNV
Downgrades: BKC, LLY, BHI Downgrades: BKC, LLY, BHI
Wednesday, August 4, 3:34 PM ET		 MannKind Narrows Loss MannKind Narrows Loss
Monday, August 2, 2:37 PM ET
MNV
MNV
MNV
Pharma Earnings: LLY, BMY Pharma Earnings: LLY, BMY
Thursday, July 22, 11:49 AM ET		 Downgrades: LLY, AKS, VIA.B Downgrades: LLY, AKS, VIA.B
Tuesday, June 29, 3:02 PM ET
MNV
MNV
MNV
Thursday's ETF with Unusual Volume: FXH Thursday's ETF with Unusual Volume: FXH
Thursday, June 24, 5:15 PM ET		 Daily Dividend Report: IVR, BA, LLY, SYK, JEF Daily Dividend Report: IVR, BA, LLY, SYK, JEF
Tuesday, June 22, 3:45 PM ET
MNV
MNV
MNV
Downgrades: CSTR, LLY, MON Downgrades: CSTR, LLY, MON
Tuesday, April 20, 5:10 PM ET		 Daily Dividend Report: JEF, GS, LLY, BK, CCL Daily Dividend Report: JEF, GS, LLY, BK, CCL
Tuesday, April 20, 2:32 PM ET
MNV
MNV
MNV
Eli Lilly Announces Earnings Eli Lilly Announces Earnings
Monday, April 19, 4:13 PM ET		 Pharma News: Label Change to Bydureon, Inspire Trial Fails Pharma News: Label Change to Bydureon, Inspire Trial Fails
Monday, March 15, 12:41 PM ET
MNV
MNV
MNV
Daily Dividend Report: BA, GE, LLY, PFE, GIS Daily Dividend Report: BA, GE, LLY, PFE, GIS
Tuesday, December 15, 3:51 PM ET		 SEC Reportedly Investigating Nine Mergers for Insider Trading SEC Reportedly Investigating Nine Mergers for Insider Trading
Thursday, December 10, 11:32 AM ET
MNV
MNV
MNV
FDA Approves United Therapeutics Drug for Hypertension  NOW PLAYING
FDA Approves United Therapeutics Drug for Hypertension
Tuesday, May 26, 11:45 AM ET
More Market News Videos | 1 2 next »
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use & Privacy Policy - Video Widget
MNV
Market News Video  |  Daily Dividends  Economic News  Large Caps  Market Movers  Upgrades/Downgrades  Weekly Market Wrap  Week Ahead Report
MNV
MNV MNV Follow marketnewsvideo on Twitter
  Stock AlertsFree email alerts when your stocks are mentioned in videos
MNV

FDA Approves United Therapeutics Drug for Hypertension | Market News Video | Copyright © 2008 - 2010, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.